R. Pate

Insider Reports History

Entity
Individual
Location
5739 Wortham Lane, Dallas, TX
Signature
/s/ Sarah Kim, attorney-in-fact for Mr. Pate
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Pate:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Option Care Health, Inc. Director Common Stock 36.1K $1.17M $32.37 Sep 3, 2024 Direct
Purple Innovation, Inc. Director Class A Common Stock 48.7K $108K $2.22 Jun 20, 2023 Direct
Teligent, Inc. Director Restricted Stock Units 150K Jul 21, 2021 Direct

Insider Reports Filed by R. Pate

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OPCH Option Care Health, Inc. Sep 3, 2024 2 -$47.4K 4 Sep 5, 2024 Director
OPCH Option Care Health, Inc. May 15, 2024 1 $0 4 May 17, 2024 Director
OPCH Option Care Health, Inc. May 9, 2024 1 $0 4 May 10, 2024 Director
PRPL Purple Innovation, Inc. Jun 20, 2023 1 $0 4 Jun 22, 2023 Director
OPCH Option Care Health, Inc. May 17, 2023 1 $0 4 Jun 7, 2023 Director
PRPL Purple Innovation, Inc. May 15, 2023 1 $50K 4 May 15, 2023 Director
PRPL Purple Innovation, Inc. Apr 27, 2023 0 $0 3 May 3, 2023 Director
OPCH Option Care Health, Inc. Oct 3, 2022 1 -$61.6K 4 Oct 5, 2022 Director
OPCH Option Care Health, Inc. Sep 1, 2022 1 -$58.9K 4 Sep 2, 2022 Director
OPCH Option Care Health, Inc. Aug 1, 2022 1 -$64.2K 4 Aug 3, 2022 Director
OPCH Option Care Health, Inc. Jul 8, 2022 1 -$57.7K 4 Jul 12, 2022 Director
OPCH Option Care Health, Inc. May 20, 2022 1 $0 4 May 24, 2022 Director
OPCH Option Care Health, Inc. Dec 21, 2021 2 -$197K 4 Jun 3, 2022 Director
TLGT Teligent, Inc. Jul 21, 2021 1 $0 4 Jul 22, 2021 Director
TLGT Teligent, Inc. May 27, 2021 1 $16.5K 4 May 27, 2021 Director
OPCH Option Care Health, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director
OPCH Option Care Health, Inc. May 10, 2021 1 $14.3K 4 May 12, 2021 Director
OPCH Option Care Health, Inc. Aug 6, 2019 2 $50.3K 4 Aug 21, 2023 Director